Boehringer Taps Ensemble Therapeutics In Deal For Macrocycle Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
In parallel with the Cambridge, Mass.-based company’s previous partnerships, Ensemble will discover synthetic macrocycle drugs that address protein-protein interactions, based on targets selected by the German pharma. Meanwhile, the biotech continues to develop its own pipeline.